This is a working overview of REV-ERB, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-03-12. Anything still debated is marked as such rather than presented as settled.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Categorical data can be either nominal or ordinal. Ordinal data has a ranked order for its values and can therefore be converted to numerical data through ordinal encoding. An example of ordinal data would be the ratings on a test ranging from A to F, which could be ranked using numbers from 6 to 1. Since there is no quantitative relationship between nominal variables' individual values, using ordinal encoding can potentially create a fictional ordinal relationship in the data. Therefore, one-hot encoding is often applied to nominal variables, in order to improve the performance of the algorithm. For each unique value in the original categorical column, a new column is created in this method. These dummy variables are then filled up with zeros and ones (1 meaning TRUE, 0 meaning FALSE). Because this process creates multiple new variables, it is prone to creating a 'big p' problem (too many predictors) if there are many unique values in the original column. Another downside of one-hot encoding is that it causes multicollinearity between the individual variables, which potentially reduces the model's accuracy. Also, if the categorical variable is an output variable, you may want to convert the values back into a categorical form in order to present them in your application. In practical usage, this transformation is often directly performed by a function that takes categorical data as an input and outputs the corresponding dummy variables. An example would be the dummyVars function of the Caret library in R.
When a beer has been brewed using a cool fermentation of around 10 °C (50 °F), compared to typical warm fermentation temperatures of 18 °C (64 °F), then stored (or lagered) for typically several weeks (or months) at temperatures close to freezing point, it is termed a "lager". During the lagering or storage phase several flavour components developed during fermentation dissipate, resulting in a "cleaner" flavour. Though it is the slow, cool fermentation and cold conditioning (or lagering) that defines the character of lager, the main technical difference is with the yeast generally used, which is Saccharomyces pastorianus. Technical differences include the ability of lager yeast to metabolise melibiose, and the tendency to settle at the bottom of the fermenter (though ale yeasts can also become bottom settling by selection); though these technical differences are not considered by scientists to be influential in the character or flavour of the finished beer, brewers feel otherwise – sometimes cultivating their own yeast strains which may suit their brewing equipment or for a particular purpose, such as brewing beers with a high abv.
=== Filming === For the scene where Baby Billy exposes himself naked to Jesse, Judy and Kelvin, Walton Goggins was offered the option of getting naked, but he declined. He said, "We've done lot of chaotic things over the course of our 12-year collaboration; I will follow Danny McBride anywhere — except there. That's one thing I won't do. Danny McBride commented, "The beautiful thing about Walton is that he's never shown his actual penis on the show. It's always a stunt double penis. Another fun fact: it's never the same penis. We've cast different elderly penises — or Peni — for all his scenes." Tim Baltz did his own stunts for his character's pole dancing, saying "I was excited, because it felt like an evolution of the character; I felt like each season there was something more ridiculous that BJ was getting into. It made perfect sense that this was the hobby, but I wasn't prepared for it, so I just started pounding creatine and training hard."
Some species of fungi live most of their life cycles as molds in soil, but upon entering a host animal, they transition to a yeast form, along with expression of virulence factors that convert them into effective and dangerous pathogens. These are known as dimorphic fungi and are typically capable of reproduction in the typical yeast fashion, including via budding. In these organisms, the yeast form transition is required for pathogenicity; if the transition is stopped somehow, the mold form does not cause disease. The rounded and separated forms of yeasts help them to spread through the bloodstream to organ systems. In some infections caused by dimorphic fungi, such as emergomycosis, respiratory symptoms are uncommon, even though the fungus initially enters through the lungs. Most molds are not dimorphic, and only a very small number of species cause dimorphic fungal disease in humans.
Sources: en.wikipedia.org
Unlike Half-Life however, armor takes the form of actual vests, and can not be replenished by chargers like health can. Unlike Half-Life and its expansions, Gunman Chronicles, however sparsely, uses cutscenes to tell key parts of the storyline. These usually appear only as transitions between different worlds and levels however, and thus most of the plot is seen through the eyes of the player like in Half-Life.
Whereas the biological half-life of estradiol given by intravenous injection is about 0.5 to 2 hours, the biological half-life of oral estradiol has a range of 13 to 20 hours due to the large and long-lasting pool of estrogen conjugates that is formed during first-pass metabolism and that serves to continuously replenish circulating estradiol levels.
== External links == Picture of Margaret Oakley Dayhoff, c. 1980. Owned by her daughter Ruth E. Dayhoff, M.D. Made available by the National Library of Medicine. Profile and photographs of Margaret O. Dayhoff in Grandma got STEM project. Information submitted to the project by Margaret Dayhoff's son-in-law Vincent, husband of Ruth E. Dayhoff. Also contains biographical information about descendants. Baby Joseph and Vrundha M. Nair .2012 Woman Innovator in Bioinformatics: Dr. Margaret Oakley Dayhoff. Adv Bio Tech:12 (01) 32–34
μoi is the standard chemical potential of the species, R is the gas constant and T is the temperature. Setting the sum for the reactants j to be equal to the sum for the products, k, so that δGr(Eq) = 0:
==== Diabetes ==== A meta-analysis reported that vitamin D supplementation significantly reduced the risk of type 2 diabetes for non-obese people with prediabetes. Another meta-analysis reported that vitamin D supplementation significantly improved glycemic control [homeostatic model assessment-insulin resistance (HOMA-IR)], hemoglobin A1C (HbA1C), and fasting blood glucose (FBG) in individuals with type 2 diabetes. In prospective studies, high versus low levels of vitamin D were respectively associated with a significant decrease in risk of type 2 diabetes, combined type 2 diabetes and prediabetes, and prediabetes. A systematic review included one clinical trial that showed vitamin D supplementation together with insulin maintained levels of fasting C-peptide after 12 months better than insulin alone.
Sources: en.wikipedia.org
== See also == Controlled Substances Act Controlled Substance Analogue Enforcement of 1986 Controlled Drugs and Substances Act Lizard Labs New chemical entity Online illicit drug vendor Operation Web Tryp Federal Analogue Act Pharmaceutical company Psychoactive Substances Act 2013 – New Zealand Psychoactive Substances Act 2016 – UK ban on all drugs based on psychoactive effect PsychonautWiki Research chemical
=== Advocacy for children === In her role as spokesperson for Child Poverty Action Group, Turner commented in the media on the relationship between low income and poor child health, and in 2008 co-authored a research report which stated that poverty was causing "devastation" in the health sector, with data showing New Zealand children had "higher rates of preventable illness and deaths from injuries than children in almost any other OECD country". The report drew attention to the fact that Maori and Pasifika children were disproportionately affected by this. In 2012, Turner, as a member of the Children's Commissioner Expert Advisory Group on Solutions to Child Poverty, contributed to a major report that explored how child poverty in New Zealand could be reduced. Turner later said she was disappointed at the response by the New Zealand government and that they had only focussed on a few areas instead of taking a fully systemic approach to reducing child poverty. This report supported the findings in a previous paper, endorsed by the New Zealand Medical Association and co-authored by Turner, which contended that overcrowding, poor nutrition, exposure to tobacco and stress contributed to creating a social environment in which the population was vulnerable and likely to have less access to health care services.
== Risks == As with any procedure, there are risks involved; these include reactions to medicine, problems breathing, bleeding, and infection. Infection is reported to occur in less than 1% of cases and is curable with antibiotics. Overall, patients with a preexisting illness are at a higher risk of getting an infection as opposed to those who are overall healthy.
Norris immediately came under suspicion and was questioned by police about Hall's murder. It was further decided to investigate the deaths of 72 people who had died on the ward while Norris was working, and a special medical panel decided that 18 of the 72 deaths should be reviewed by independent medical experts. The experts confirmed police suspicions that the deaths of three women were as a result of lethal injections of insulin, which causes hypoglycaemic attacks, but they also identified two more victims, one who had also died of insulin poisoning and another who had survived a massive injected overdose. Along with Ethel Hall, none of these women were diabetic (nor was anyone else on the ward), and all of them had been admitted to the wards simply suffering from broken hips. In any case, the amount of insulin Hall had been injected with was far in excess of what a diabetic patient would need. They were also all murdered while in non-emergency orthopaedic wards, where only minor, non-life-threatening things such as broken bones are treated. When questioned about the cases Norris said "he seemed to have been unlucky over the last 12 months." The first three incidents occurred at Leeds General Infirmary. They began in May 2002, which also notably happened to be when the detailed probationary monitoring of Norris's early progress as a newly qualified nurse ended.
EGF is the founding member of the EGF-family of proteins. Members of this protein family have highly similar structural and functional characteristics. Besides EGF itself other family members include:
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.